Tonight, I watched the London Calling 2024 session on “Optimizing QC testing of mRNA vaccines and therapeutics.” Telmo Graca from Lonza, Switzerland, was the speaker for this session. They had learning objectives for the ten-minute talk. The three learning objectives focused on providing an overview of the requirements for mRNA therapeutics, the collaboration process between […]